In human leukemia patients, CTLs specific for leukemia-associated antigens (LAAs) are detected in peripheral blood, e.g., by staining with MHC-peptide tetramers, suggesting that the spontaneous CTL response to LAAs may counteract leukemia progression [12–15]. This evidence concerns the gene HLA-C and leukemia.